User profiles for Anne-Catrin Uhlemann

Anne-Catrin Uhlemann

Columbia University Medical Center
Verified email at columbia.edu
Cited by 13054

[HTML][HTML] Systematic review of gut microbiota and major depression

SG Cheung, AR Goldenthal, AC Uhlemann… - Frontiers in …, 2019 - frontiersin.org
Background: Recently discovered relationships between the gastrointestinal microbiome and
the brain have implications for psychiatric disorders, including major depressive disorder (…

Artemisinins: mechanisms of action and potential for resistance

S Krishna, AC Uhlemann, RK Haynes - Drug Resistance Updates, 2004 - Elsevier
Artemisinins form the most important class of antimalarial currently available, particularly
because they are effective against parasites resistant to almost all the other classes. Their …

[HTML][HTML] Evolution of community-and healthcare-associated methicillin-resistant Staphylococcus aureus

AC Uhlemann, M Otto, FD Lowy, FR DeLeo - Infection, genetics and …, 2014 - Elsevier
Staphylococcus aureus is a prominent cause of human infections globally. The high prevalence
of infections is compounded by antibiotic resistance—a significant problem for treatment. …

Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number

RN Price, AC Uhlemann, A Brockman, R McGready… - The Lancet, 2004 - thelancet.com
Background The borders of Thailand harbour the world's most multidrug resistant Plasmodium
falciparum parasites. In 1984 mefloquine was introduced as treatment for uncomplicated …

[HTML][HTML] Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir

…, MK Annavajhala, Y Guo, Z Sheng, AC Uhlemann… - Nature, 2023 - nature.com
Nirmatrelvir, an oral antiviral targeting the 3CL protease of SARS-CoV-2, has been demonstrated
to be clinically useful against COVID-19 (refs. ). However, because SARS-CoV-2 has …

COVID-19 neuropathology at columbia university irving medical center/New York presbyterian hospital

…, A Soung, K Tanji, AF Teich, D Agalliu, AC Uhlemann… - Brain, 2021 - academic.oup.com
Many patients with SARS-CoV-2 infection develop neurological signs and symptoms; although,
to date, little evidence exists that primary infection of the brain is a significant contributing …

Decreasing pfmdr1 Copy Number in Plasmodium falciparum Malaria Heightens Susceptibility to Mefloquine, Lumefantrine, Halofantrine, Quinine, and Artemisinin

ABS Sidhu, AC Uhlemann… - The Journal of …, 2006 - academic.oup.com
The global dissemination of drug-resistant Plasmodium falciparum is spurring intense
efforts to implement artemisinin (ART)–based combination therapies for malaria, including …

[HTML][HTML] Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data

…, P Khairallah, AM Chong, H Park, AC Uhlemann… - Modern …, 2020 - nature.com
The novel coronavirus SARS-CoV-2 (coronavirus disease 19, or COVID-19) primarily causes
pulmonary injury, but has been implicated to cause hepatic injury, both by serum markers …

Molecular and Pharmacological Determinants of the Therapeutic Response to Artemether-Lumefantrine in Multidrug-Resistant Plasmodium falciparum Malaria

RN Price, AC Uhlemann, M van Vugt… - Clinical Infectious …, 2006 - academic.oup.com
Background . Our study examined the relative contributions of host, pharmacokinetic, and
parasitological factors in determining the therapeutic response to artemether-lumefantrine (AL)…

A single amino acid residue can determine the sensitivity of SERCAs to artemisinins

AC Uhlemann, A Cameron… - Nature structural & …, 2005 - nature.com
Artemisinins are the most important class of antimalarial drugs. They specifically inhibit
PfATP6, a SERCA-type ATPase of Plasmodium falciparum. Here we show that a single amino …